MedPath

PANHEMATIN

PANHEMATIN

Approved
DIN Number

02478765

Drug Class

Human

Market Date

Dec 5, 2018

Company
HC

recordati rare diseases canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02478765
AIG Number0160470001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
B06AB01 HEMATIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
Health Canada Classification

ACTIVE INGREDIENTS (1)

HEMINActive
Strength: 268 MG / VIAL
Monograph: HEMIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.